Broadwood pledges cooperation with STAAR Surgical after Alcon deal vote
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
December 17, 2025 1:17 PM ESTExpresses Confidence in STAARs Future and the Opportunity for Significant Value Creation
Believes STAAR is Worth at Least $50 Per Share If the Company Is Run in Best Interest of Shareholders
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today issued the following letter to the Board of Directors (the Board) of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAARs outstanding common stock, continues to urge its fellow shareholders to vote... More
